LET 2.5 Pill - yellow round, 6mm
Pill with imprint LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Dr. Reddy's Laboratories Limited .
Letrozole is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LET 2.5
Letrozole
- Imprint
- LET 2.5
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories Limited
- National Drug Code (NDC)
- 55111-0646 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
hypromelloses,
lactose monohydrate,
magnesium stearate,
polyethylene glycol,
povidone,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "LET 2.5"
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.